The Toronto Stock Exchange reports that Profound Medical Corp. will list additional shares. As stated in its prospectus supplement dated Sept. 6, 2023, the company will issue up to $30-million (U.S.) to the public pursuant to the at-the-market (ATM) distribution procedures as defined by National Instrument 44-102, Shelf Distributions.

According to the TSX, the ATM sales will be made directly on the TSX, the Nasdaq Stock Market, or any other trading market for the shares in Canada or the United States, during the period commencing Sept. 6, 2023, and ending upon the termination of the equity distribution agreement dated Sept. 6, 2023. As a result of the ATM procedures, prices may vary as between purchasers and during the period of distribution.